Key result
Pathogenic KLHL40 variants, including a novel frameshift variant c.543del, were identified in five Chinese patients with nemaline myopathy 8, with an estimated incidence of 2.95 to 4.59 per million.
Case Report (n=5)
No
Expands the mutation spectrum of KLHL40 in nemaline myopathy 8 and estimates its incidence in the Chinese population, suggesting its inclusion in carrier screening panels.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to NEM8 in Chinese neonates with arthrogryposis; extends KLHL40 variant spectrum but leaves broader prevalence and therapies open.
Background Homozygous or compound heterozygous variants in the KLHL40 gene cause nemaline myopathy 8 (NEM8), a severe autosomal recessive muscle disorder characterized by prenatal polyhydramnios, fetal akinesia or hypokinesia, joint contractures, fractures, respiratory failure and dysphagia. Currently, 46 individuals with NEM8 have been described in the literature, and 30 variants in KLHL40 have been identified. Results Here, we reported five individuals from four unrelated Chinese families who presented common features of nemaline myopathy and infrequent clinical characteristics. Whole-exome sequencing (WES) was used to identify the causative gene. WES identified a recurrent missense variant c.1516A>C (p.Thr506Pro) and a novel frameshift variant c.543del (p.Ser182Profs*17) in KLHL40 in patient 1, a nonsense variant c.602G>A (p.Trp201*) and a missense variant c.1516A>C (p.Thr506Pro) in KLHL40 in patient 2, and homozygous variant c.1516A>C (p.Thr506Pro) in KLHL40 in patient 3 and both siblings (patients 4 and 5), all of which were confirmed by Sanger sequencing. Next, we estimated the incidence of this disorder in the southern and northern Chinese population to be 4.59/10 6 and 2.95/10 6 , respectively, based on the cumulative allele frequency of pathogenic variants in internal database. Conclusion The results of our study expand the mutation spectrum of KLHL40 and enrich our understanding of the clinical characteristics of NEM8. Genetic counseling was provided for the four families involved in this study. Given the severity and the relatively high incidence of this condition, we strongly suggest that KLHL40 be incorporated into a carrier screening panel for the Chinese population.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2022) conducted a case report in Nemaline myopathy 8 (NEM8) (n=5). Pathogenic KLHL40 variants was evaluated on Identification of causative genetic variants and estimation of disease incidence. Pathogenic KLHL40 variants, including a novel frameshift variant c.543del, were identified in five Chinese patients with nemaline myopathy 8, with an estimated incidence of 2.95 to 4.59 per million.
Synapse has enriched 10 related papers. Consider them for comparative context: